Latest cloning Stories
How you can delay umbilical cord clamping and bank your baby's cord blood NEW YORK, April 17, 2013 /PRNewswire/ -- Americord Registry, a leader in the advancement of umbilical cord blood, cord tissue and placenta tissue banking, today announced continued support for parents that elect to delay cord clamping and bank cord blood. According to Americord there is little impact on the ability to collect cord blood when parents choose to delay the clamping of the umbilical cord. While a...
Breakthrough data presented at The Vatican Stem Cell Conference MONTCLAIR, N.J., April 16, 2013 /PRNewswire/ -- A preliminary research study, which found that adult stem cells may be functionally reprogrammed to act like younger cells, was presented by Dr. Vincent Giampapa at The Second International Vatican Stem Cell Conference: Regenerative Medicine - A Fundamental Shift in Science and Culture, from within the Vatican, held between April 11-13, 2013. The research, which has...
Stem cells are different from all other cells in our body because they retain the remarkable genetic plasticity to self-renew indefinitely as well as develop into cell types with more specialized functions. However, this remarkable self-renewal capacity comes with a price, as stem cells can become seeds of cancer. Identifying genetic programs that maintain self-renewing capabilities therefore is a vital step in understanding the errors that derail a normal stem cell, sending it on a path to...
When it comes to delivering genes to living human tissue, the odds of success come down the molecule. The entire therapy — including the tools used to bring new genetic material into a cell — must have predictable effects. Now, a new screening process will simplify non-viral transfection, providing a method researchers and clinicians use to find an optimal set of biomaterials to deliver genes to cells. Developed by William Murphy, the Harvey D. Spangler professor of biomedical...
Rayshell Clapper for redOrbit.com - Your Universe Online What, Why and How? What exactly is human genetic engineering (HGE or HGM)? It’s a simple question with a complex answer. According to the Association of Reproductive Health Professionals (ARHP), HGM is a process by which scientists and medical professionals alter the genetic makeup, or DNA, in a living human cell. Ideally, HGM would be used to fix defective genes that cause diseases and other genetic complications. In one...
Georgia Institute of Technology A new separation process that depends on an easily-distinguished physical difference in adhesive forces among cells could help expand production of stem cells generated through cell reprogramming. By facilitating new research, the separation process could also lead to improvements in the reprogramming technique itself and help scientists model certain disease processes. The reprogramming technique allows a small percentage of cells – often taken from...
[Watch the Video: Engineering Blood Vessels ] redOrbit Staff & Wire Reports - Your Universe Online Researchers from the University of Michigan (UM) have reportedly discovered a way to overcome one of the primary obstacles to growing replacement hearts, lungs, kidneys and other new organs. Those replacement organs often fail because of the difficulties associated with building blood vessels in order to keep their tissues alive. Now UM associate biomedical engineering professor...
Explosive growth in the field of tissue engineering and regenerative medicine has led to innovative and promising applications and techniques, many of which are now being tested in human clinical trials. Hot topics, research advances, and transformative publications that are driving the field forward are highlighted in a comprehensive overview of the field presented in Tissue Engineering, Part B, Reviews, a peer-reviewed journal from Mary Ann Liebert, Inc. publishers. The article is available...
John Malone of Liberty Media Corporation invests $2 million into biotech startup MONTCLAIR, N.J., March 27, 2013 /PRNewswire/ -- CellHealth(TM) Institute (CHI), a new biotechnology company that provides breakthrough products, services and lifestyle education in the emerging category of personalized cell health has launched with the backing of key investors. John Malone Ph.D., chairman of Liberty Media Corporation (NASDAQ: LMCA) has invested $2 million in CellHealth Institute. (Logo:...
PORT ST LUCIE, Fla., March 27, 2013 /PRNewswire/ -- CleanPath Resources Corp (OTC Pink: CLNP) (www.re-load.biz) announced today an exclusive agreement with the BioSwan(TM) division of Hemp, Inc. The agreement gives CleanPath exclusive rights to the new NutraLOAD(TM) stem enhancement product. NutraLOAD(TM) is an innovative new product shown to significantly increase the production of PluriCells(TM) in the body. PluriCells(TM) is the trademarked name given to the recently...
